| INTRODUCTION
Quantification of radioactive iodine (i.e., iodine-131) uptake (RAIU) is a standard, widely-accepted method of estimating thyroid hormonogenesis based on the degree of trapping and organification of radioactive iodine in the thyroid gland. The measurement of RAIU was introduced into clinical practice over 60 yr ago 1, 2 and currently remains an important tool in the investigation of various etiologies of hyperthyroidism. [3] [4] [5] [6] [7] [8] Twenty-four hour (24-h) RAIU is also a key component of the formula used to calculate the dosage of iodine needed when treating hyperthyroidism with radioactive iodine therapy (RAIT). [9] [10] [11] [12] [13] Based on a prescribed activity concentration in the thyroid at 24 h post administration (K, in units of MBq/g) and the fractional 24-h RAIU, the therapeutic iodine activity is given by the formula below, with K typically ranging from 3.0 to 8. 
| MATERIALS AND METHODS
The study was conducted under the approval of the Ottawa Hospital
Research Ethics Board. To estimate reproducibility of measurement, we analyzed 36 consecutive patients referred for thyroid scintigraphy and RAIU at our two affiliated sites, which employ identical thyroid uptake systems, each consisting of a 2″ NaI crystal, photomultiplier tube, and multichannel analyzer (Capintec Thyroid Uptake System, Captus© 3000). RAIU is measured 24 h after oral administration of approximately 370 kBq of 131 I-NaI in capsule form (Jubilant-DraxImage, Kirkland, Quebec) following standard procedure guidelines. 19 Briefly, prior to administration, the capsule of 131 I-NaI is placed in a neck phantom holder and counts are measured using the gamma probe; a background count without the capsule is also obtained. At time of uptake, typically 24 h following administration, similar measurements are performed over the patient's neck and thigh (patient background), using identical 1-min acquisitions and a 364 keV AE 10% photopeak energy window. RAIU is computed as the ratio of background-corrected 24-h neck counts to backgroundcorrected capsule counts; as noted, neck background is approximated by count rate over the patient's thigh.
For the purpose of obtaining reproducibility estimates, we varied our standard protocol only in that each measurement (capsule, background, 24-h neck, 24-h thigh) was performed in duplicate. Repositioning of patients and capsules was also performed between duplicate measurements to simulate variability in the uncertainty estimation due to positioning. Final diagnosis of patients is based on available clinical information, blood work, and thyroid scintigraphy as well as RAIU.
2.A | Statistical analysis
Repeated measurements were compared using a Bland-Altman anal- 
| RESULTS
Final diagnoses of the 36 patients included in the reproducibility analysis are listed in Table 1 . Initial RAIU ranged from 0.3% to 72%
(33 AE 19%) and second RAIU from 0.3% to 73% (33 AE 19%).
Differences in RAIU between the repeated measurements ranged from À4.8% to 3.1% (À0.1 AE 1.6%) (Figs. 1 and 2 ) and the difference between test and retest value was not statistically significant (P = 0.63). There was no significant correlation between DRAIU and average RAIU (r = À0.06, P = 0.74). Reproducibility of the RAIU measurement was calculated to be 1.1% and absolute 95% LSC was 3.2%.
T A B L E 1 Diagnoses of the 36 patients with duplicated measurements included in the reproducibility analysis. 
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APPENDIX
Root-mean-square standard deviation (SD RMS ) is computed using the following formula:
where SD i represents the standard deviation of the repeated measures of the ith subject and m is the number of subjects. The least significant change (LSC), with one baseline and one follow up measurements, is computed according to the following formula:
where Z' is a value chosen according to the level of statistical confidence. For statistical confidence levels of 80%, 90%, 95%, and 99%, the Z' values are 1.28, 1.65, 1.96, and 2.58 respectively. A total number of 30 subjects is recommended when reproducibility is assessed with one baseline and one follow-up measurement. 18 Using 30 subjects with duplicated measurements provides 30 degrees of freedom, which ensure statistical validity of the analysis. 18 
